Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0001209191-23-025114

Chief Executive Officer sold 8,408 shares at $3.71 ($31,183)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Brainard Diana · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-04-19 Sale : show line 1 in the form 10b5-1 −8,408 $3.71 $31,183 921,164 D
Open-market sales · 8,408 sh · avg $3.71 · $31,183
Loading xslF345X04/doc4.xml…